Covered recipient · General Payments record
ZACHARY M WIERCINSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care
General Payments · PY2022–2024
$908.81
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $649.22 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $252.89 | 14 |
| Organon LLC | $181.14 | 2 |
| ABBVIE INC. | $63.53 | 3 |
| Merck Sharp & Dohme Corporation | $30.64 | 2 |
| Acerta Pharma LLC | $29.22 | 1 |
| IBSA Pharma Inc. | $22.81 | 1 |
| Phadia US Inc. | $19.40 | 1 |
| PFIZER INC. | $18.44 | 1 |
| Exact Sciences Corporation | $16.93 | 1 |
| Lilly USA, LLC | $14.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.46 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409402 | CMS |
| ABBVIE INC. | $20.10 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409404 | CMS |
| ABBVIE INC. | $21.97 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108409406 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.22 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105411015 | CMS |
| Exact Sciences Corporation | $16.93 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114525126 | CMS |
| IBSA Pharma Inc. | $22.81 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142981503 | CMS |
| Lilly USA, LLC | $14.22 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135991886 | CMS |
| Merck Sharp & Dohme LLC | $14.57 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141981661 | CMS |
| Merck Sharp & Dohme LLC | $16.07 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141948702 | CMS |
| Novo Nordisk Inc | $20.72 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100469862 | CMS |
| Novo Nordisk Inc | $15.72 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100568100 | CMS |
| Novo Nordisk Inc | $19.96 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100335346 | CMS |
| Novo Nordisk Inc | $20.72 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100653045 | CMS |
| Novo Nordisk Inc | $7.26 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100335446 | CMS |
| Novo Nordisk Inc | $18.14 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100631123 | CMS |
| Novo Nordisk Inc | $18.84 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100601982 | CMS |
| Novo Nordisk Inc | $22.52 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304509 | CMS |
| Novo Nordisk Inc | $16.59 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100434039 | CMS |
| Novo Nordisk Inc | $18.14 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100611910 | CMS |
| Novo Nordisk Inc | $16.94 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100542582 | CMS |
| Novo Nordisk Inc | $19.14 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100612255 | CMS |
| Novo Nordisk Inc | $18.01 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100225394 | CMS |
| Novo Nordisk Inc | $20.19 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100643067 | CMS |
| Organon Llc | $160.44 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136311231 | CMS |
| Organon Llc | $20.70 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136311229 | CMS |
| PFIZER INC. | $18.44 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131067509 | CMS |
| Phadia US Inc. | $19.40 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067588132 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.